1 day-1.28%
1 week-1.28%
1 month+11.04%
3 months-1.83%
6 months+11.17%
Current year+11.94%
1 month 17.44
Extreme 17.44
20
Current year 16.56
Extreme 16.555
20.13
1 year 15.94
Extreme 15.94
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Chief Tech/Sci/R&D Officer 54 2023-04-30
Date Insider Type Main position Quantity % Market Cap. Importance
11/2/26 Issuer sale

Executive/Senior Manager

-668,619 0.0348%
11/2/26 Issuer sale

Chief Operating Officer

-1,271,058 0.0662%
11/2/26 Issuer sale

Executive/Senior Manager

-254,485 0.0132%
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Sector
-
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Kenvue Inc.
  1. Stock Market
  2. Stocks
  3. KVUE Stock